Morphic Presents New Biomarker Data at DDW 2023 Supporting MORF-057 Program in Ulcerative Colitis
Morphic Holding, Inc. (MORF)
Last morphic holding, inc. earnings: 11/12 04:24 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
WALTHAM, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF) today announced the presentation of new preclinical data in the MORF-057 IBD development program that are consistent with previous findings and add new support to mechanistic understanding of the molecule’s activity in a nonhuman primate (NHP) model of ulcerative colitis. The poster presentation was made at Digestive Disease Week (DDW) 2023. “The data presented at DDW continue to refine and reinforce our understanding of the pharmacokinetic-pharmacodynamic relationship of a4ß7 inhibition with respect to cellular biomarkers and MORF-057’s translation to treatment of patients. Further, these results link Morphic’s small molecule a4ß7 inhibitors with the pharmacology associated with approved anti-integrin IBD treatments,” commented Bruce Rogers, PhD, President of Morphic. The study presented at DDW examines longitudinal changes in circulating biomarkers in nonhuman primates (NHP) infused with stepwise
Show less
Read more
Impact Snapshot
Event Time:
MORF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MORF alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MORF alerts
High impacting Morphic Holding, Inc. news events
Weekly update
A roundup of the hottest topics
MORF
News
- Here's Why We're Not Too Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn Situation [Yahoo! Finance]Yahoo! Finance
- MORF NEWS: Johnson Fistel has Commenced an Investigation on Behalf of Morphic Holding Company ShareholdersAccesswire
- Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024 [Yahoo! Finance]Yahoo! Finance
- Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024GlobeNewswire
- MORF NEWS: Johnson Fistel has Commenced an Investigation on Behalf of Morphic Holding Company ShareholdersGlobeNewswire
MORF
Earnings
- 4/25/24 - Beat
MORF
Analyst Actions
- 3/8/24 - Canaccord Genuity
MORF
Sec Filings
- 4/26/24 - Form 8-K
- 4/26/24 - Form S-3ASR
- 4/26/24 - Form 424B5
- MORF's page on the SEC website